Derek Theler: Diabetes Warrior

The Marvel’s New Warriors actor is the face of Dexcom’s Call of the Warrior campaign, launching this month. Derek spoke to Beyond Type 1 about what it means to be a superhero — both on set and while managing diabetes.

In Depth with Medtronic’s Chief Patient Officer

There’s so much innovative technology, new services, and better education and training. It’s all going to be integrated with your life, in the car, on your body, in the house, with your family, and even with your doctor.

Grant Helps ViaCyte Pursue T1D Cure

The California Institute for Regenerative Medicine (CIRM) awarded ViaCyte a $20 million dollar grant to continue its cutting-edge research towards finding a functional cure for T1D.

The Power of Community

When we face a diabetes diagnosis, one of the best ways to cope with it is by recognizing that the diabetes online community (DOC) is eager and willing to be there for you.

Switching from an Animas Pump – Know Your Options

Here are the insulin pumps available on the market in the United States and their defining features to help you chose the best fit for you or your loved one.

Fast-acting Insulin, Fiasp, Gets FDA Approval

Last Friday the U.S. Food and Drug Administration approved Novo Nordisk’s latest fast-acting insulin, Fiasp, for treatment use by adults with diabetes.

Advances in Diabetes Care Apple-style

This summer Apple announced a fall update to its Health app incorporating the ability to track insulin delivery doses.

Animas Pumps Discontinued

Johnson & Johnson’s Diabetes Care Company, Animas Corporation has just announced the intended discontinuation of manufacturing The Animas® Vibe® and OneTouch Ping® insulin pumps.

How accurate are blood glucose meters?

A new independent study reveals that not all BGMs on the market report clinically accurate blood glucose levels.

Curing Type 1 Diabetes: An Interview with Dr. Faustman

“This is one of the rare trials of the world where we don't think we need to intervene at the moment you end up in the emergency room with new onset Type 1 diabetes."

Tandem Announces Dexcom G5 Mobile Integration for t:slim X2

August 28, 2017 - Tandem Diabetes Care announces FDA approval and commercial launch of the t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring (CGM) integration

Study Shows CGM Benefits Extend to Those with Type 2 Diabetes

Over 24 weeks, Type 2 patients lowered their HbA1C levels and reported high levels of satisfaction using Dexcom's CGM system.

Immune Therapy Trial Points To Potential T1D Prevention

In a clinical trial for a form of immunotherapy aimed at treating childhood food allergies, British scientists discovered the treatment in fact appeared to stop the immune system from attacking insulin production in those newly diagnosed with Type 1 diabetes.

Stem Cell-derived Treatment One Step Closer to Type 1 Diabetes Cure

Regenerative medicine company and Beyond Type 1 grantee ViaCyte treats first patients in PEC-Direct stem cell replacement trial for high-risk T1D patients.

Diabetes Tech: How To Keep Up, While Keeping Your Hopes Up

With so much diabetes news flooding our lives, how does one manage his or her hopes and expectations around realizable treatments and technological lifestyle improvements?